Abstract Virtual screening of novel entry inhibitor scaffolds mimicking primary receptor CD4 of HIV-1 gp120 was carried out in conjunction with evaluation of their potential inhibitory activity by molecular modeling. To do this, pharmacophore models presenting different sets of the hotspots of cellular receptor CD4 for its interaction with gp120 were generated. These models were used as the templates for identification of CD4-mimetic candidates by the pepMMsMIMIC screening platform. Complexes of these candidates with gp120 were built by high-throughput ligand docking and their stability was estimated by molecular dynamics simulations and binding free energy calculations. As a result, five top hits that exhibited strong attachment to the two well-conserved hotspots of the gp120 CD4-binding site were selected for the final analysis. In analogy to CD4, the identified compounds make hydrogen bonds with Asp-368gp120 and multiple van der Waals contacts with the gp120 residues that bind to Phe-43CD4, resulting in destruction of the critical interactions of gp120 with Phe-43CD4 and Arg-59CD4. The complexes of the CD4-mimetic candidates with gp120 show relative conformational stability within the molecular dynamics simulations and expose the high percentage occupancies of intermolecular hydrogen bonds, in line with the data on the binding free energy calculations. In light of these findings, the identified compounds are considered as good scaffolds for the development of new functional antagonists of viral entry with broad HIV-1 neutralization.
van der Waals       0.9999999972175146^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Van_der_Waals_force   

mimetic                       0.4466646382929538^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mimesis               

entry inhibitor               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Entry_inhibitor       

binding site                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Binding_site          

free energy calculations      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Gibbs_free_energy     

residues                      0.9999999999940883^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Amino_acid            

gp120                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Envelope_glycoprotein_GP120

scaffolds                     0.9999999997294253^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Scaffolding           

gp120                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Envelope_glycoprotein_GP120

Phe                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Phenylalanine         

pharmacophore                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Pharmacophore         

gp120                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Envelope_glycoprotein_GP120

Asp                           0.9999999964682047^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Aspartic_acid         

free energy calculations      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Gibbs_free_energy     

scaffolds                     0.9999999997294253^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Scaffolding           

gp120                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Envelope_glycoprotein_GP120

Arg                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Arginine              

molecular dynamics            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Molecular_dynamics    

receptor                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Receptor_(biochemistry)

hydrogen bonds                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hydrogen_bond         

screening                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/High-throughput_screening

gp120                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Envelope_glycoprotein_GP120

light                         0.9996927133969261^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Light                 

mimetic                       0.4466646382929538^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mimesis               

CD4                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/CD4                   

hydrogen bonds                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hydrogen_bond         

antagonists                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Receptor_antagonist   

hotspots                      0.9992845385984878^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Hotspot_(Wi-Fi)       

CD4                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/CD4                   

cellular receptor             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Receptor_(biochemistry)

hotspots                      0.9992845385984878^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Hotspot_(Wi-Fi)       

intermolecular                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Intermolecular_force  

neutralization                0.961893329495059^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Neutralisation_(immunology)

occupancies                   0.9999993701123623^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Occupancy             

ligand docking                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Docking_(molecular)   

gp120                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Envelope_glycoprotein_GP120

gp120                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Envelope_glycoprotein_GP120

high-throughput               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/High-throughput_screening

molecular modeling            0.9999306727095462^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Computational_chemistry

inhibitory                    0.9999856898341073^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Enzyme_inhibitor      

molecular dynamics            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Molecular_dynamics    

hits                          0.6809999187938897^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Web_analytics         

screening                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/High-throughput_screening

HIV-1                         0.9999756745650625^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Subtypes_of_HIV       

analogy                       0.9999999528147339^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Analogy               

final analysis                0.9999999791932626^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Final_Analysis        

Phe                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Phenylalanine         

CD4                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/CD4                   

viral entry                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Viral_entry           

CD4                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/CD4                   

attachment                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Virus                 

HIV-1                         0.9999756745650625^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Subtypes_of_HIV       

CD4                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/CD4                   

CD4                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/CD4                   

